ARACELY URIBE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family EDINBURG, TX NPI 1104475334

General Payments — all program years on this page

$482.37

  • Category: General Payments
  • Program years: PY2021
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $482.37 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $482.3723

By paying entity

Latest program year (PY2021) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $482.3723

Records — PY2021 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
763509492 Boehringer Ingelheim Pharmaceuticals, Inc. $15.38 04/01/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
787778597 Janssen Pharmaceuticals, Inc $17.79 05/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795809083 AbbVie Inc. $22.22 06/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
802116151 GlaxoSmithKline, LLC. $17.80 06/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810675089 Novo Nordisk Inc $15.95 07/20/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810917759 Novo Nordisk Inc $16.74 01/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810917767 Novo Nordisk Inc $15.83 03/29/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810917773 Novo Nordisk Inc $6.51 04/28/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810917781 Novo Nordisk Inc $25.47 05/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
810917787 Novo Nordisk Inc $16.61 08/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811073323 Novo Nordisk Inc $15.81 05/26/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811073329 Novo Nordisk Inc $18.34 06/17/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811220101 Novo Nordisk Inc $24.74 05/13/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
811448379 Novo Nordisk Inc $20.07 06/03/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
818838727 Lilly USA, LLC $20.76 04/08/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
818840503 Lilly USA, LLC $14.62 07/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829292967 AstraZeneca Pharmaceuticals LP $9.58 07/22/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829434797 AstraZeneca Pharmaceuticals LP $108.33 06/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829939831 AstraZeneca Pharmaceuticals LP $11.29 06/05/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
838511837 Esperion Therapeutics, Inc. $15.74 06/23/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848398319 Merck Sharp & Dohme Corporation $19.76 06/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
848678695 Merck Sharp & Dohme Corporation $21.98 05/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
851646349 Optinose US, Inc. $11.05 03/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.